• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心房颤动、充血性心力衰竭与大脑中动脉

Atrial Fibrillation, Congestive Heart Failure, and the Middle Cerebral Artery.

作者信息

Ameriso S F, Sager P, Fisher M

机构信息

Department of Neurology University of Southern California School of Medicine Los Angeles, CA.

Department of Medicine (Cardiology) University of Southern California School of Medicine.

出版信息

J Neuroimaging. 1992 Oct;2(4):190-4. doi: 10.1111/jon199224190.

DOI:10.1111/jon199224190
PMID:27309151
Abstract

Atrial fibrillation and congestive heart failure are risk factors for ischemic stroke usually attributed to cardiac embolism. To define potential alternative mechanisms, patients with atrial fibrillation and congestive heart failure were investigated by transcranial Doppler. Middle cerebral artery (MCA) blood flow velocities were analyzed in neurologically asymptomatic patients with nonvalvular (n = 10) and valvular (n = 13) atrial fibrillation, patients in normal sinus rhythm with congestive heart failure (n = 13), and control subjects (n = 11). Compared to patients in sinus rhythm with congestive heart failure and to control subjects, patients in both atrial fibrillation groups had significantly greater beat-to-beat variation in peak, mean, and diastolic velocities and in pulsatility index. Peak, mean, and diastolic MCA velocities in patients with atrial fibrillation and those with congestive heart failure were significantly less than those in control subjects. Patients with nonvalvular atrial fibrillation had a higher pulsatility index compared to each of the other three groups. These findings demonstrate substantial nonemboligenic alterations of the intracranial circulation associated with atrial fibrillation and congestive heart failure, and also provide an intracranial hemodynamic profile that may distinguish valvular from nonvalvular atrial fibrillation.

摘要

心房颤动和充血性心力衰竭是通常归因于心脏栓塞的缺血性卒中的危险因素。为了确定潜在的其他机制,采用经颅多普勒对心房颤动和充血性心力衰竭患者进行了研究。分析了无神经症状的非瓣膜性心房颤动患者(n = 10)、瓣膜性心房颤动患者(n = 13)、窦性心律伴充血性心力衰竭患者(n = 13)以及对照受试者(n = 11)的大脑中动脉(MCA)血流速度。与窦性心律伴充血性心力衰竭患者和对照受试者相比,两个心房颤动组患者的峰值、平均和舒张期速度以及搏动指数的逐搏变化均显著更大。心房颤动患者和充血性心力衰竭患者的MCA峰值、平均和舒张期速度显著低于对照受试者。与其他三组中的每一组相比,非瓣膜性心房颤动患者的搏动指数更高。这些发现表明与心房颤动和充血性心力衰竭相关的颅内循环存在大量非栓塞性改变,并且还提供了一种可能区分瓣膜性心房颤动和非瓣膜性心房颤动的颅内血流动力学特征。

相似文献

1
Atrial Fibrillation, Congestive Heart Failure, and the Middle Cerebral Artery.心房颤动、充血性心力衰竭与大脑中动脉
J Neuroimaging. 1992 Oct;2(4):190-4. doi: 10.1111/jon199224190.
2
[Risk factors for stroke in Chinese with non valvular atrial fibrillation: a case-control study].[中国非瓣膜性心房颤动患者卒中的危险因素:一项病例对照研究]
Zhonghua Nei Ke Za Zhi. 2003 Mar;42(3):157-61.
3
Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial.阿哌沙班与华法林在伴有心房颤动和心脏瓣膜病患者中的比较:来自心房颤动患者阿哌沙班减少卒中和其他血栓栓塞事件(ARISTOTLE)试验的结果。
Circulation. 2015 Aug 25;132(8):624-32. doi: 10.1161/CIRCULATIONAHA.114.014807. Epub 2015 Jun 23.
4
Anxiety sensitivity moderates prognostic importance of rhythm-control versus rate-control strategies in patients with atrial fibrillation and congestive heart failure: insights from the Atrial Fibrillation and Congestive Heart Failure Trial.焦虑敏感在心房颤动和充血性心力衰竭患者的节律控制与心率控制策略的预后重要性中起调节作用:来自心房颤动和充血性心力衰竭试验的见解。
Circ Heart Fail. 2012 May 1;5(3):322-30. doi: 10.1161/CIRCHEARTFAILURE.111.964122. Epub 2012 Mar 22.
5
Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts.肾功能障碍作为非瓣膜性心房颤动患者中风和全身性栓塞的预测因子:ROCKET AF(利伐沙班每日一次,口服,直接 Xa 因子抑制与维生素 K 拮抗剂预防中风和房颤试验)和 ATRIA(心房颤动抗凝和危险因素)研究队列中 R(2)CHADS(2)指数的验证。
Circulation. 2013 Jan 15;127(2):224-32. doi: 10.1161/CIRCULATIONAHA.112.107128. Epub 2012 Dec 3.
6
[Venous flow velocity patterns and cardiac function studied by Doppler echocardiography].
J Cardiol. 1988 Sep;18(3):775-86.
7
[Autoantibodies: new upstream targets of paroxysmal atrial fibrillation in patients with congestive heart failure].[自身抗体:充血性心力衰竭患者阵发性心房颤动的新上游靶点]
J Cardiol. 2002 Nov;40(5):217-23.
8
Comparison of rate versus rhythm control in patients with atrial fibrillation and a pacemaker.心房颤动合并起搏器患者的速率控制与节律控制比较。
Am J Cardiol. 2013 Jun 15;111(12):1759-63. doi: 10.1016/j.amjcard.2013.02.031. Epub 2013 Mar 27.
9
Comparison of permanent left ventricular and biventricular pacing in patients with heart failure and chronic atrial fibrillation: a prospective hemodynamic study.心力衰竭合并慢性心房颤动患者永久性左心室起搏与双心室起搏的比较:一项前瞻性血流动力学研究。
Card Electrophysiol Rev. 2003 Dec;7(4):315-24. doi: 10.1023/B:CEPR.0000023167.11038.8f.
10
Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease studies.在伴有心血管疾病的不耐受血管紧张素转化酶抑制剂患者中进行的替米沙坦单独治疗与替米沙坦联合雷米普利全球终点试验/替米沙坦随机评估研究中的高心血管风险患者中,血压和其他新发性心房颤动决定因素。
J Hypertens. 2012 May;30(5):1004-14. doi: 10.1097/HJH.0b013e3283522a51.